VISN 5 MIRECC - General Publications 2010 - MIRECC / CoE
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

MIRECC / CoE

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
 

VISN 5 MIRECC - General Publications 2010

 

About Us • Clinical • Education • Research
VISN 5 MIRECC home

 

Carpenter WT, Jr. Conceptualizing schizophrenia through attenuated symptoms in the population. Am J Psychiatry, 167(9):1013-1016, 2010. PMID:20826849

William R. Keller, Bernard A. Fischer, William T. Carpenter, Jr. Revisiting the Diagnosis of Schizophrenia: Where have we been and Where are We Going? CNS Neuroscience & Therapeutics (2):83-8, 2010

Slade E, Dixon L, Semmel S: Emergency Department Visits from 2001 to 2006: Trends in Visit Duration, Psychiatric Services 2010 Sep;61(9):878-84

Rosenberg S, Goldberg R, Dixon L, Wolford G, Slade E, Himelhoch S, Gallucci G, Potts W, Tapscott S, Welsh C: Assessing the STIRR Model of Best Practices for Blood‑Borne Infections in Clients with Severe Mental Illness, Psychiatric Services 2010 Sep;61(9):885-91.

Khaykin E, Ford DE, Pronovost PJ, Dixon L, Daumit GL. National Estimates of Adverse Events during Non-Psychiatric Hospitalizations for Persons with Schizophrenia. General Hospital Psychiatry, 2010 Jul-Aug;32(4):419-25.

Brown C, Leith J, Dickerson F, Medoff D, Kreyenbuhl J, Fang L, Goldberg, R., Potts, W., Dixon, L. (2010). Predictors of mortality in patients with serious mental illness and co-occurring type 2 diabetes. Psychiatry Research, 2010 177, 250-254.

Nossel I, Calmes C, Brown C, Kreyenbuhl J, Goldberg R, Fang L, Dixon L: Patterns of Emergency Room Use for Medical Conditions among those with Serious Mental Illness, Psychiatric Services, 2010 61, 1251-4.

Ascher-Svanum H, Zhu B, Faries DE, Salkever D, Slade EP, Peng X, Conley RR. The cost of relapse and the predictors of relapse in the treatment of schizophrenia, BMC Psychiatry, 10:2, 2010, doi: 10.1186/1471-244X-10-2

Brown, L.D., & Lucksted, A. (2010). Chapter 2 – Theoretical Foundations of Mental Health Self-Help. In L. D. Brown & S. Wituk (Eds.), Mental Health Self-Help: Consumer and Family Initiatives (pp. 19-38). New York: Springer.

Goldberg, R. and Resnick, S. (2010). US Department of Veteran Affairs (VA) Efforts to Promote Psychosocial Rehabilitation and Recovery. Psychiatry Rehabilitation Journal, 33(4): 255-258.

Forbes, CB, Blanchard, JJ, Bennett, M, Horan, W.P., Kring, A., & Gur, R. (2010). Initial development and preliminary validation of a new negative symptom measure: The Clinical Assessment Interview for Negative Symptoms. Schizophrenia Research, 124, 36-42.

Weiner, E., Conley, R. R., Ball, M. P., Feldman, S., Gold, J. M., Kelly, D. L., Wonodi, I., McMahon, R. P., & Buchanan, R. W. (2010). Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine. Neuropsychopharmacology, 35(11), 2274-83.